GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Other Current Receivables

Celadon Pharmaceuticals (LSE:CEL) Other Current Receivables : £0.00 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Other Current Receivables?

Celadon Pharmaceuticals's Other Current Receivables for the quarter that ended in Jun. 2024 was £0.00 Mil.


Celadon Pharmaceuticals Other Current Receivables Historical Data

The historical data trend for Celadon Pharmaceuticals's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Other Current Receivables Chart

Celadon Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Receivables
- 0.32 - - -

Celadon Pharmaceuticals Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Celadon Pharmaceuticals Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.


Celadon Pharmaceuticals Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Celadon Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
32-33 Cowcross Street, London, GBR, EC1M 6DF
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis. It operates only in the UK and has only one geographical area.

Celadon Pharmaceuticals Headlines

No Headlines